## 



## 

## 



## 

## 

## 

## 



## 

## 

## 

## 

## 

## 



## 



## 

## 



## 

## 



## 

## 

## 



## 

## 

## 

## 



## 

## 

|Membership<br>Breakdown||||2022|2021|
|---|---|---|---|---|---|
|Honorary<br>Fellows||||||
|Life Fellows/Full<br>Members|(not being Honorary||Fellows)|147|148|
|Fellows||||539|608|
|Retired<br>Fellows/Full<br>Members||||176|179|
|Out-of-area<br>Fellows||||28|28|
|Full Members<br>(Non-Medically||qualified)||30|21|
|Members of Sections||||||
|FY1-2<br>Doctor/Dentist||||70|93|
|SpeciaIty Trainee||||110|135|





## 

## 

## 

## 

## 



## 

## 

## 



## 

## 

## 

## 




## 

## 



## 

## 

## 

## 

## 



## 

## 

## 

## 



## 

## 



## 

## 

## 

## 

## 

## 



## 

||||Unrestricted|Restricted|Total funds|Total funds|
|---|---|---|---|---|---|---|
||||funds|funds|2022|2021|
|||Note|E|E|E|E|
|Income from:|||||||
|Donations<br>and legacies||3|14,796|100|14,896|182,195|
|Charitable<br>activities:|||54,610|450|55,060|59,499|
|Investments||s|12,314||12,319|10,537|
|Total income|||81,720|555|82,275|252,231|
|Expenditure<br>on:|||||||
|Raising funds|||7,295||7,295|5,598|
|Charitable<br>activities:||7|116,154|870|117,024|103,857|
|Total expenditure|||123,449|870|124,319|109,455|
|Net income/(expenditure)||before|||||
|net gains/(losses)|on investments||(41,729)|(315)|(42,044)|142,776|
|Net gains/(losses)|on investments||(12,024)||(12,024)|107,167|
|Net income/(expenditure)||for the|||||
|year||9|(53,753)|(315)|(54,068)|249,943|
|Transfer<br>between<br>funds|||(250)|250|||
|Net movement<br>in|funds for|the year|(54,003)|(65)|(54,068)|249,943|
|Reconciliation<br>of|funds||||||
|Tota<br>I funds<br>brought|forward||785,030|19,202|804,232|554,289|
|Total funds carried forward|||731,027|19,137|750,164|804,232|





## 

||||||Balance She|et||||
|---|---|---|---|---|---|---|---|---|---|
|||||as|at 31 March|2022||||
|||||Note|2022|||2021||
|Fixed assets||||||||||
|Tangible assets||||13||8,903|||3,790|
|Investments||||14||692,477|||697,227|
|Total fixed assets||||||701,380|||701,017|
|Current assets||||||||||
|Debtors||||15|9,706||13,058|||
|Cash at bank and|in|hand||16|58,753||103,644|||
|Total current assets|||||68,459||116,702|||
|Liabilities||||||||||
|Creditors:<br>amounts||falling||||||||
|due<br>in less than|one year||||(19,675)||(13,487)|||
|Net current assets||||||48,784|||103,215|
|Total assets less|current||liabilities|||750,164|||804,232|
|Net assets||||||750,164|||804,232|
|Funds ofthe charity:||||||||||
|Restricted<br>income|funds|||19||19,137|||19,202|
|Unrestricted<br>income||funds||20||731,027|||785,030|
|Total charity funds||||||750,164|||804,232|





## 

||||||Note|2022|2021|
|---|---|---|---|---|---|---|---|
|||||||E||
|Cash provided<br>by/(used||in) operating||activities|22|(43,793)|139,052|
|Cash flows from investing|activities:|||||||
|Dividends,<br>interest,<br>and||rents|from investments|||12,319|10,537|
|Proceeds from sale of tangible|||fixed assets|||||
|Purchase<br>of tangible<br>fixed assets||||||(6,143)|(3,499)|
|Proceeds from sale of investments||||||660,363|270,281|
|Purchase<br>of investments||||||(667,637)|(385,232)|
|Cash provided<br>by/(used||in) investing||activities||(1,098)|(107,913)|
|Increase/(decrease)<br>in cash||and|cash|||||
|equivalents<br>in the year||||||(44,891)|31,139|
|Cash and cash equivalents|at the||beginning|ofthe year||103,644|72,505|
|Cash and cash equivalents||at|the end ofthe year|||58,753|103i644|





## 

## 

## 

## 



## 

## 

## 

## 

## 

## 



## 

## 

## 

## 



## 

|3|Income||from dona|tions|and legacies||||
|---|---|---|---|---|---|---|---|---|
||Current||reporting|period||Unrestricted<br>f|Restricted<br>f|Total 2022<br>f|
||Donations|||||4,796|100|4,896|
||Legacies|||||10,000||10,000|
||Total|||||14,796|100|14,896|
||Previous||reporting|period||Unrestricted<br>f|Restricted<br>f|Tota I 2021<br>f|
||Donations|||||31,920|275|32,195|
||Legacies|||||150,000||150,000|
||Total|||||181,920|275|182,195|
|4|Income||from charitable||activities||||
||Current||reporting|period||Unrestricted|Restricted<br>f|Tota I 2022|
||Subscriptions|||||54,610||54,610|
||Awards|and prizes|||||450|450|
||Total|||||54,610|450|55,060|
||Previous||reporting|period||Unrestricted<br>f|Restricted<br>f|Total 2021<br>f|
||Subscriptions|||||58,999||58,999|
||Awards|and prizes||||150|350|500|
||Total|||||59,149|350|59,499|





|5|Investment<br>income|Investment<br>income|||||
|---|---|---|---|---|---|---|
||Current|reporting<br>period||Unrestricted<br>E|Restricted<br>f|Total 2022<br>E|
||Income from bank deposits|||5||10|
||Dividends|received||12,309||12,309|
|||||12,314||12,319|
||Previous|reporting<br>period||Unrestricted|Restricted<br>f|Tota I 2021|
||Income from bank deposits|||7|13|20|
||Dividends|received||10,517||10,517|
|||||10,524|13|10,537|
|6|Cost of|raising funds|||||
|||||2022|202i||
||Investment<br>management||costs|7,295|5,598||
|||||7,295|5,598||





## 

## 

|||||
|---|---|---|---|
|Current<br>reporting|period||Tota I 2022|
||||E|
|Staff costs|||92,757|
|Office Expenditure|||5,632|
|Prizes|||870|
|Direct Debit Service|||456|
|Grant to library|||7,500|
|Depreciation|||1,030|
|Meeting<br>Expenses|||785|
|Service Charge to MANDEC|||3,000|
|Professional<br>Fees|||3,114|
|Rent for use of library|||500|
|Section Meetings||||
|Governance<br>costs||||
|(see note 8)|||1,380|
||||117,024|
|Previous<br>reporting|period||Tota I 2021|
|Staff costs|||91,627|
|Office Expenditure|||2,606|
|Prizes|||450|
|Direct Debit Service|||456|
|Grant to library||||
|Depreciation|||1,789|
|Meeting<br>Expenses|||1,481|
|Service Charge to MANDEC|||3,000|
|Professional<br>Fees|||232|
|Governance<br>costs||||
|(see note 8)|||2,100|
||||103,741|
|||2022|2021|
|Restricted<br>expenditure||870|350|
|Unrestricted<br>expenditure||116,154|103,507|
|||117,024|103,857|





## 

|Analysis ofgovernance<br>and|Analysis ofgovernance<br>and|sup|port costs|port costs||||
|---|---|---|---|---|---|---|---|
|Current<br>reporting<br>period|||Basis of<br>apportionment|||Governance|Total 2022<br>f|
|Accountancy<br>services|||Governance|||1,380|1,380|
|||||||1,380|1,380|
|Previous<br>reporting<br>period|||Basis of<br>apportionment|||Governance<br>f|Total 2021<br>f|
|Accountancy<br>services|||Governance|||2,100|2,100|
|||||||2,100|2,100|
|Net income/(expenditure)||for|the year|||||
|This is stated after charging/(crediting):|||||2022<br>f|2021f||
|Depreciation|||||1,030|1,789||
|Examiner's<br>remuneration|- accountancy|||fees|1,150|1,050||
|Examiner's<br>remuneration|- payroll||bureau<br>fees||227|232||
|Independent<br>examiner's|fees||||700|700||
|Staff costs||||||||
|Staff costs during<br>the year were as follows:||||||||
||||||2022<br>f|2021f||
|Wages and salaries|||||74,356|73,590||
|Social security costs|||||2,600|2,510||
|Pension costs|||||15,801|15,527||
|Redundancy<br>and termination||costs||||||
||||||92,757|91,627||



## 

## 



## 

## 

## 

## 

|Fixed assets: tangible assets||
|---|---|
||Office|
||equipment|
|Cost|E|
|At 1 April 2021|12,037|
|Additions|6,143|
|D isposa Is||
|At 31 March 2022|18,180|
|Depreciation||
|At 1 April 2021|8,247|
|Charge for the year|1,030|
|Disposals||
|At 31 March 2022|9,277|
|Net book value||
|At 31 March 2022|8,903|
|At 31 March 2021|3,790|





|Investments|||||
|---|---|---|---|---|
||||2022|2021|
||||E||
|Market value at the|start of the year||697,227|475,109|
|Add: additions<br>to investments||at cost|667,637|385,232|
|Disposals at carrying|value||(660,363)|(270,281)|
|Add net gain/(loss)|on revaluation||(12,024)|107,167|
|Market value at the|end of the|year|692,477|697,227|
|Investments<br>at fair|value comprised:||||
|Equities|||427,881|449,057|
|Fixed interest securities|||163,776|90,591|
|Alternative<br>Investments|||100,820|157,579|
||||692,477|697,227|



## 

|l5|Investments<br><br>Debtors|are all carried|at fair value and|are all traded<br>in quoted|public mark|
|---|---|---|---|---|---|
|||||2022|2021|
||||||E|
||Income tax receivable|||4,560|4,271|
||Trade debtors|||168|748|
||Prepayments|and accrued|income|4,708|8,039|
||Other debtors|||270||
|||||9,706|13,058|
|16|Cash at bank|and in hand||||
|||||2022|2021|
|||||E|E|
||Cash at bank|and on hand||58,753|103,644|
|||||58,753|103,644|





## 

## 

|Credi|tors: am|ount|s<br>falling due within|one year||
|---|---|---|---|---|---|
|||||2022|2021|
||||||E|
|Trade|creditors|||13,719|3,470|
|Other|creditors|and|accruals|5,956|10,017|
|||||19,675|13,487|



## 



## 




|Previous reporting|Previous reporting|Previous reporting|Balance at||||||Balance at|
|---|---|---|---|---|---|---|---|---|---|
||period||1 April||||||31 March|
||||2020<br>E|Income<br>f||Expenditure<br>E||Transfers<br>f|2021<br>E|
|Restricted<br>Funds||||||||||
|K Bloor Memorial<br>Fund|||3,465||4||||3,469|
|A Hunter|Memorial|Fund|8,662||134||||8,796|
|j Steward|Memorial|Fund|1,967||||||1,967|
|Paediatric|Fund||1,591|||||1,210|2,801|
|Anaesthesia<br>Prize Fund|||||350||(350)|||
|Psychiatry|||963||||||963|
|Imaging|Prize Fund||||150||||150|
||||16,648||638||(350)|1,210|18,146|
|Endowment<br>Funds||||||||||
|Cooper|Bequest||1,056||||||1,056|
||||1,056||||||1,056|
|Total|||17,704||638||(350)|1,210|19,202|
|Name|of|||||||||
|restricted<br>fund|||Description,|nature|and|purposes|ofthe|fund||





## 

|Analysis o|f movement|in unrestrict|ed<br>funds|||||
|---|---|---|---|---|---|---|---|
|Current||||||||
|rePorting<br>Penod|Balance<br>at ] April||Expenditur|Gains/(loss<br>es) on||As at|31|
||2021|Income|e|investment|Transfers|March|2022|
|General|744,676|81,660|(115,124)|(12,024)|(250)|698,938||
|Medicine||||||||
|Surgical||60|(60)|||||
|Pathology||||||||
|Anaesthesi|154||||||154|
|Imaging|200||(75)||||125|
|Website||||||||
|and digital<br>oresence|40,000||(8,190)|||31,810||
||785,030|81,720|(123,449)|(12,024)|(250)|731,027||
|Previous||||||||
|reporting<br>per lod|Balance<br>at 1 April||Expenditur|Gains/(loss<br>es) on||As at|31|
||2020|Income|e|investment|Transfers|March|2021|
||E|E|E|E|E|E||
|General|537,038|251,593|(109,105)|107,167|(42,017)|744,676||
|Surgical|(8)||||8|||
|Pathology|(799)||||799|||
|Anaesthesi|154||||||154|
|Imaging|200||||||200|
|Website||||||||
|and digital||||||||
|Presence|||||40,000|40,000||
||536,585|251,593|(109,105)|107,167|(1,210)|785,030||



## 



## 

## 

|Analysis|of net|assets between<br>f|unds||||
|---|---|---|---|---|---|---|
|Current|||||||
|Reporting|||||||
|Period|||General|Designated|Restricted||
||||fund|funds|funds|Total|
|Tangible|fixed assets||8,903|||8,903|
|Fixed asset investments|||692,477|||692,477|
|Other net|current|assets/(liabilities)|(2,442)|32,089|19,137|48,784|
|Creditors|of more|than one year|||||
|Total|||698,938|32,089|19,137|750,164|
|Previous|||||||
|Reporting|||||||
|Period|||General|Designated|Restricted||
||||fund|funds|funds|Total|
|Tangible|fixed assets||3,790|||3,790|
|Fixed asset investments|||697,227|||697,227|
|Other net|current|assets/(liabilities)|43,659|40,354|19,202|103,215|
|Creditors|of more|than one year|||||
|Total|||744,676|40,354|19,202|804,232|



|22|Reconciliation<br>of net|movement|movement|in|funds to net|cash flow from operating|cash flow from operating|activities|
|---|---|---|---|---|---|---|---|---|
|||||||2022|2021||
|||||||E|||
||Net income/(expenditure)<br>for the<br>Adjustments<br>for:||||year|(54,068)|249,943||
||Depreciation<br>charge|||||1,030|1,788||
||(Gains)/losses<br>on investments|||||12,024|(107,167)||
||Dividends,<br>interest|and rents|from||investments|(12,319)|(10,537)||
||Decrease/(increase)|in debtors||||3,352|3,127||
||Increase/(decrease)|in creditors||||6,188|1,898||
||Net cash provided<br>by/(used||in)|operating|||||
||activities|||||(43,793)|139,052||



